Tag: Clinical Trials

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is ‘safe’ or effective, only that the trial may be conducted.

Alphabet’s Verily Teams Up with Big Pharma

Verily, the health and life sciences company under Google parent-company Alphabet, is moving into the clinical trials space. The company announced Tuesday strategic alliances with the pharmaceu...

Boehringer Ingelheim Published New Data in Rare Disease

preclinical-research
Boehringer Ingelheim announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVC) in patients with systemic sclerosis associated i...

4th Clinical Trials in Central and Eastern Europe Conference

Join us at the Clinical Trials in Central & Eastern Europe Forum, the premier meeting-place for the region’s clinical trials’ sector. Taking place 28th – 29th May at Hotel Bristol in Vienna, this ...

Actelion Presented Latest Post-Hoc Analysis from the GRIPHON Study

janssen
Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has presented results of a post-hoc exploratory analysis of the GRIPHON study in patients with pulmo...

New Data Demonstrated the Effectiveness of AstraZeneca’s Symbicort Turbuhaler

astrazeneca
New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol) as a potential anti-inflammat...

ImmunoGen Urged by FDA to Run Another Phase III Trial for Mirvetuximab Soravtansine

ImmunoGen, based in Waltham, Mass., announced that the U.S. Food and Drug Administration (FDA) recommended it run a new Phase III clinical trial of mirvetuximab soravtansine in high folate receptor (F...

Agios Pharma’s Tibsovo Showed Positive Results in Cholangiocarcinoma Study

biotech-lab
Agios Pharmaceuticals, headquartered in Cambridge, Mass., announced that its Tibsovo (ivosidenib) hit its primary endpoint in the Phase III ClarIDHy trial in patients with cholangiocarcinoma with an i...

4th Clinical Trials in Central and Eastern Europe Conference

Join us at the Clinical Trials in Central & Eastern Europe Forum, the premier meeting-place for the region’s clinical trials’ sector. Taking place 28th – 29th May at Hotel Bristol in Vienna, this ...

Zydus Cadila announces Desidustat’s phase III trial

Drug firm Zydus Cadila on Wednesday announced phase III clinical trials of Desidustat, an investigational new drug targeted at treating anaemia in non-dialysis dependent chronic kidney disease patient...

India to Promote Clinical Research

The Health Ministry has recently notified New Drugs and Clinical Trials Rules, 2019, with a goal to promote clinical research in the nation, for lowering the time of application approval to 30 days fo...

Biogen and Eisai Stop Trials of Alzheimer’s Treatment

Biogen and Eisai, Co., Ltd. (Tokyo, Japan) announced the decision to discontinue the global Phase 3 trials, ENGAGE and EMERGE, designed to evaluate the efficacy and safety of aducanumab in patients wi...

AZ’s Diabetes Drug Reduces Heart Failure Risk

Farxiga reduced hospitalisation for heart failure regardless of ejection fraction status. Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that Farxi...

Phase 4 Results of BMS-Pfizer Trial

The Bristol-Myers Squibb-Pfizer Alliance announced results from the Phase 4 AUGUSTUS trial evaluating Eliquis® (apixaban) versus vitamin K antagonists (VKAs) in patients with non-valvular atrial fibri...

Envigo Launches Integrated Solution for FIH Trials

Envigo, a leading provider of non-clinical contract research services and research models, announced the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment progra...

Monthly and Daily Treatment of HIV-1 Showed Same Efficacy

Johnson & Johnson’s subsidiary Janssen Pharmaceuticals and ViiV Healthcare have revealed 48 week data from two pivotal Phase III trials showing injections of their long-acting, monthly combination...

Allergan MDD Treatment Not Differentiate from Placebo

allergan
Allergan plc announced topline results from three pivotal studies of rapastinel as an adjunctive treatment of Major Depressive Disorder (MDD). In three acute studies (RAP-MD-01,-02,-03), the rapastine...